Showing results (1261-1270 of 5,257) with videos related to

Sort By:
Pageof 526
Oncology|May 26, 2025
Efficacy of Fusion Imaging and Cone-Beam Computed Tomography-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Poorly Visualized on UltrasonographyKeizo Kato, Hiroshi Abe, Makiko Ika, et al.
Oncology|March 5, 2024
Decision-Making at Swissmedic, the Swiss Regulatory Agency, with a Focus on (Neo)adjuvant Cancer TreatmentsMatea Zosso-Pavic, Qiyu Li, Stephanie Juritz, et al.
Oncology|March 5, 2024
Comprehensive Study of Chromosomal Copy Number Variations and Genomic Variations Predicting Overall Survival in Myelodysplastic SyndromesNehakumari Maurya, Chandrakala Shanmukhaiah, Somprakash Dhangar, et al.
Oncology|February 14, 2024
Impact of HER2-Low Status in Metastatic Gastric Cancer: A Real-World Retrospective Cohort StudyOlcun Umit Unal, Seval Akay, Gurkan Gul, et al.
Oncology|January 24, 2024
Prognostic Factors among Patients with Resected Non-Adenocarcinoma of the LungNozomu Motono, Takaki Mizoguchi, Masahito Ishikawa, et al.
Oncology|February 6, 2024
Prognostic Value of the Geriatric Nutritional Risk Index in Previously Untreated Patients with Advanced Non-Small Cell Lung Cancer Treated with a Combination Therapy of Anti-PD-1/-PD-L1 Antibodies and Platinum-Based Chemotherapy: A Multicenter Retrospective StudyTaro Hirabayashi, Kei Sonehara, Ryota Ozawa, et al.
Oncology|January 18, 2024
Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter StudyTakanori Suzuki, Kentaro Matsuura, Yuta Suzuki, et al.
Oncology|January 17, 2024
Variations in Patterns of Prescribing Durvalumab in Stage III Lung Cancer: A Survey of Australian Medical OncologistsUdit Nindra, Victoria Bray, Deme Karikios, et al.
Oncology|January 17, 2024
Is Older Age an Independent Prognostic Factor of Survival in Metastatic Colorectal Cancer?Patricia Toquero, Rebeca Mondéjar, Nuria Romero-Laorden, et al.
Oncology|September 8, 2024
Assessment of Cardiovascular Events Caused by New-Generation Androgen Receptor Pathway Inhibitors Used for Prostate Cancer: A Real-World Study in JapanRikuto Masuda, Yoshihiro Noguchi, Haruka Aizawa, et al.
Pageof 526